BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29521941)

  • 1. Stroma - A Double-Edged Sword in Pancreatic Cancer: A Lesson From Targeting Stroma in Pancreatic Cancer With Hedgehog Signaling Inhibitors.
    Gu J; Saiyin H; Fu D; Li J
    Pancreas; 2018 Apr; 47(4):382-389. PubMed ID: 29521941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonizing the Hedgehog Pathway with Vismodegib Impairs Malignant Pleural Mesothelioma Growth In Vivo by Affecting Stroma.
    Meerang M; Bérard K; Felley-Bosco E; Lauk O; Vrugt B; Boss A; Kenkel D; Broggini-Tenzer A; Stahel RA; Arni S; Weder W; Opitz I
    Mol Cancer Ther; 2016 May; 15(5):1095-105. PubMed ID: 26839306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-stroma interaction in orthotopic primary pancreatic cancer xenografts during hedgehog pathway inhibition.
    Chang Q; Foltz WD; Chaudary N; Hill RP; Hedley DW
    Int J Cancer; 2013 Jul; 133(1):225-34. PubMed ID: 23280784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the hedgehog pathway targets the tumor-associated stroma in pancreatic cancer.
    Hwang RF; Moore TT; Hattersley MM; Scarpitti M; Yang B; Devereaux E; Ramachandran V; Arumugam T; Ji B; Logsdon CD; Brown JL; Godin R
    Mol Cancer Res; 2012 Sep; 10(9):1147-57. PubMed ID: 22859707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hedgehog signaling: from the cuirass to the heart of pancreatic cancer.
    Di Marco M; Macchini M; Vecchiarelli S; Sina S; Biasco G
    Pancreatology; 2012; 12(4):388-93. PubMed ID: 22898642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal response to Hedgehog signaling restrains pancreatic cancer progression.
    Lee JJ; Perera RM; Wang H; Wu DC; Liu XS; Han S; Fitamant J; Jones PD; Ghanta KS; Kawano S; Nagle JM; Deshpande V; Boucher Y; Kato T; Chen JK; Willmann JK; Bardeesy N; Beachy PA
    Proc Natl Acad Sci U S A; 2014 Jul; 111(30):E3091-100. PubMed ID: 25024225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Hedgehog pathway activation in cancer and implications for therapy.
    Scales SJ; de Sauvage FJ
    Trends Pharmacol Sci; 2009 Jun; 30(6):303-12. PubMed ID: 19443052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition.
    Miyazaki Y; Matsubara S; Ding Q; Tsukasa K; Yoshimitsu M; Kosai K; Takao S
    Mol Cancer; 2016 Jun; 15(1):49. PubMed ID: 27349387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a potent hedgehog pathway inhibitor capable of activating caspase8-dependent apoptosis.
    Chen Q; Zhang H; Wu M; Wang Q; Luo L; Ma H; Zhang X; He S
    J Pharmacol Sci; 2018 Jul; 137(3):256-264. PubMed ID: 30064819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer.
    Xu FG; Ma QY; Wang Z
    Cancer Lett; 2009 Oct; 283(2):119-24. PubMed ID: 19232458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the Hedgehog pathway induces autophagy in pancreatic ductal adenocarcinoma cells.
    Xu Y; An Y; Wang X; Zha W; Li X
    Oncol Rep; 2014 Feb; 31(2):707-12. PubMed ID: 24297612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrations and therapeutics involving the developmental pathway Hedgehog in pancreatic cancer.
    Kelleher FC; McDermott R
    Vitam Horm; 2012; 88():355-78. PubMed ID: 22391312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-pharmacodynamic analysis of vismodegib in preclinical models of mutational and ligand-dependent Hedgehog pathway activation.
    Wong H; Alicke B; West KA; Pacheco P; La H; Januario T; Yauch RL; de Sauvage FJ; Gould SE
    Clin Cancer Res; 2011 Jul; 17(14):4682-92. PubMed ID: 21610148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinated hedgehog signaling induces new hair follicles in adult skin.
    Sun X; Are A; Annusver K; Sivan U; Jacob T; Dalessandri T; Joost S; Füllgrabe A; Gerling M; Kasper M
    Elife; 2020 Mar; 9():. PubMed ID: 32178760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with Hedgehog pathway inhibitors.
    Low JA; de Sauvage FJ
    J Clin Oncol; 2010 Dec; 28(36):5321-6. PubMed ID: 21041712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hedgehog inhibitors: a patent review (2013 - present).
    Xin M
    Expert Opin Ther Pat; 2015 May; 25(5):549-65. PubMed ID: 25726713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies.
    Bahrami A; Khazaei M; Bagherieh F; Ghayour-Mobarhan M; Maftouh M; Hassanian SM; Avan A
    J Cell Physiol; 2017 Nov; 232(11):2931-2937. PubMed ID: 28083912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in pancreatic cancer.
    Kim EJ; Simeone DM
    Curr Opin Gastroenterol; 2011 Sep; 27(5):460-6. PubMed ID: 21778878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal hedgehog signaling maintains smooth muscle and hampers micro-invasive prostate cancer.
    Yang Z; Peng YC; Gopalan A; Gao D; Chen Y; Joyner AL
    Dis Model Mech; 2017 Jan; 10(1):39-52. PubMed ID: 27935821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hedgehog signaling and pancreatic tumor development.
    Lauth M; Toftgård R
    Adv Cancer Res; 2011; 110():1-17. PubMed ID: 21704226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.